July 2010 Company Updates and Additions

Ablynx Abraxis BioScience Abviva Actelion Adimab Aduro BioTech Affymax Ambicare Health Archer Biosciences Ariad Pharmaceuticals Asuragen AsymmetRx Bio-Path Holdings Biomoda Bioniche Life Sciences Biotrion Biovest International BioVex Bryan Oncor C.R. Bard Calithera Biosciences CellCentric CellPoint Cervelo Pharmaceuticals Charles River Laboratories Conatus Pharmaceuticals Covidien CT Atlantic CvergenX Durect Dynavax Technologies Elan Evotec Exact Sciences ExonHit Therapeutics Femta Pharmaceuticals Fuisz Pharma Gentium Geron GlycoMimetics (GMI) HemaQuest Pharmaceuticals Hologic iBio iKaryos Diagnostics Illumina Immune Design (IDC) ImmunoGen Immunotope Immunovaccine (IMV)

IncellDx Infinity Pharmaceuticals Integrated Diagnostics Intellikine InteRNA Technologies Jubilant Organosys Life Technologies M2Gen Merck KGaA Metamark Genetics Microarrays (MI) Midatech Minomic Intermational Momotaro-Gene MultiCell Technologies Oasmia Pharmaceutical Ohara Pharmaceutical Oncothyreon Osta Biotechnologies OvaGene Pacific Biosciences Pathwork Diagnostics Pfizer Phage Pharmaceuticals Pharma Omnium International PharmaGap PPD QIAGEN QRxPharma Quest PharmaTech Radient Pharmaceuticals (RPC) RedPath Integrated Pathology Rheonix Roche Diagnostics Rottapharm Madaus Rules-Based Medicine (RBM) Saladax Biomedical (SBI) Scil Proteins SenoRx Shionogi Spectrum Pharmaceuticals T-Ray Science Tekmira Pharmaceuticals Theravance Transcept Pharmaceuticals Transgene VaxGen Vermillion Zetiq Technologies